Opendata, web and dolomites

ASTRO_ECM TERMINATED

Deciphering the role of astrocytes in chronic depression.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ASTRO_ECM project word cloud

Explore the words cloud of the ASTRO_ECM project. It provides you a very rough idea of what is the project "ASTRO_ECM" about.

debilitating    labeling    first    released    function    clinicians    induce    cellular    suggests    largely    goals    matrix    receptor    silencing    molecules    inadequate    neurobiological    efforts    organization    alters    designer    genetically    cognitive    coordinated    options    expression    preclinical    vector    disorder    drugs    modulation    ameliorate    activated    defeat    alterations    chronic    mediating    patients    unknown    despite    exclusively    hippocampus    contribution    social    valid    vs    demonstrated    proteome    depression    metabolic    genes    behavioural    visualization    engineered    composition    disrupted    integrative    physiology    astrocytes    unravel    depressed    assisted    primarily    viral    interventions    subjected    extracellular    ecm    synthesized    treatment    employ    impairment    dys    psychiatric    substrates    relay    therapeutic    model    mice    worldwide    astrocyte    pathophysiology    manifestation    astrocytic    establishing    alike    dreadds    people    morphology    depressive    controls    uncover    assembly    molecular   

Project "ASTRO_ECM" data sheet

The following table provides information about the project.

Coordinator
DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV 

Organization address
address: SIGMUND FREUD STRASSE 27
city: BONN
postcode: 53127
website: www.dzne.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 159˙460 €
 EC max contribution 159˙460 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2018
 Duration (year-month-day) from 2018-05-01   to  2020-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DEUTSCHES ZENTRUM FUR NEURODEGENERATIVE ERKRANKUNGEN EV DE (BONN) coordinator 159˙460.00

Map

 Project objective

Depression is a debilitating psychiatric disorder that affects 1 in 7 people worldwide. Despite coordinated efforts from researchers and clinicians alike, the neurobiological substrates of depression remain largely unknown. As a result, therapeutic options against depression are inadequate. Using a valid preclinical model, I recently demonstrated that depression alters the molecular composition of astrocytes and the organization of extracellular matrix (ECM), an assembly of molecules that are primarily synthesized and released by astrocytes. This results in disrupted information relay in the hippocampus and in cognitive impairment, both commonly seen in depressed patients. Thus, my work suggests a role of astrocytic (dys)function in the depressive state. In the proposed project, I aim to unravel the contribution of astrocytes in the pathophysiology of depression. First, I will address how the depressive state affects astrocyte proteome, morphology and function. Second, I will address the role of astrocytes and astrocyte-derived ECM in the manifestation of depression at the molecular, cellular and the behavioural level. To reach my goals, I will make use of genetically engineered mice that allow for visualization, metabolic labeling and targeting of astrocytes. These mice will be subjected to social defeat to induce a chronic depressive state. I will study astrocyte morphology, physiology and proteome alterations in depressed mice vs. controls. After establishing astrocyte-specific changes, I will employ i) viral vector-assisted silencing of the expression of astrocytic genes contributing to the ECM and ii) designer receptor exclusively activated by designer drugs (DREADDs)-assisted modulation of astrocyte activity. I will then assess whether these interventions can ameliorate the depressive state. With this integrative approach I aim to uncover novel molecular pathways mediating the depressive state and to identify new targets for the treatment of depression.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ASTRO_ECM" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ASTRO_ECM" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Photonic Radar (2019)

Implementation of Long Reach Hybrid Photonic Radar System and convergence over FSO and PON Networks

Read More  

CLIMACY (2020)

Practices of Climate Diplomacy and Uneven Policy Responses on Climate Change on Human Mobility

Read More  

LICONAMCO (2019)

Light-controlled nanomagnetic computation schemes

Read More